Skip to content
OpenCapital
Get started

BioCryst Pharmaceuticals BCRX Increase (Decrease) in Inventories

Increase (Decrease) in Inventories at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$338K+66.5%
ALN
Alnylam PharmaceuticalsALNY
——
Amgen logo
AmgenAMGN
——
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
——

Other financials

Income statement

See full
Revenue$156.4M+7.5%
Gross profit$151.0M+7.1%
Operating income-$701.6M-3,405%
Net income-$721.8M-2,255,763%
EPS (diluted)-$2.98—

Balance sheet

See full
Cash & equivalents$173.4M+62.2%
Total debt$411.8M+24.7%
Total equity-$553.8M-22.6%
Total assets$465.1M-3.1%

Cash flow

See full
Operating cash flow-$61.8M-125%
CapEx$403.0K+182%
Free cash flow-$62.2M-125%

Valuation

See full
Market cap$2.37B+52.3%
Enterprise value$2.6B+46.7%
P/S2.7×-0.4×

Profitability

See full
Gross margin97.8%+0.8pp
Operating margin-43.1%-49.7pp
Net margin-51.7%-69.7pp
FCF margin35%—

Returns & leverage

See full
Return on equity-882.8%—
Debt / equity0.1×—
Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's increase (decrease) in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioCryst Pharmaceuticals's increase (decrease) in inventories?
BioCryst Pharmaceuticals (BCRX) reported increase (decrease) in inventories of $4.85M in Q1 2026.
How has BioCryst Pharmaceuticals's increase (decrease) in inventories changed year-over-year?
BioCryst Pharmaceuticals's increase (decrease) in inventories increased by 457.1% year-over-year, from $870K to $4.85M.
What is the long-term trend for BioCryst Pharmaceuticals's increase (decrease) in inventories?
Over 2 years (2021 to 2025), BioCryst Pharmaceuticals's increase (decrease) in inventories has grown at a -56.8% compound annual growth rate (CAGR), from $8.77M to $1.64M.
What does increase (decrease) in inventories mean?
Tracks the net change in the value of raw materials, work-in-progress, and finished goods held by the company. Fluctuations reflect changes in production levels, supply chain management, and anticipated future demand for products.